| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 9e-13 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-12 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-10 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |